Copyright: ©Author(s) 2026.
World J Gastroenterol. Oct 21, 2026; 32(39): 121904
Published online Oct 21, 2026. doi: 10.3748/wjg.121904
Published online Oct 21, 2026. doi: 10.3748/wjg.121904
Figure 1 Patients with Goligher grade I internal hemorrhoids receiving foam sclerotherapy were evaluated using standardized clinical and endoscopic features.
Endoscopic Hemorrhoid Recurrence Score was developed and externally evaluated, with exploratory endoscopic and histopathological biological verification. The score provides recurrence-risk stratification and may inform the design of future risk-adapted follow-up studies. Endo-HRS: Endoscopic Hemorrhoid Recurrence Score.
- Citation: Zhang FY, Xu LM, Gao FY, Wang W, Lin WL, Zhang H, Wang KZ, Wang QJ, Jin AJ, Yang RP, Qu CY, Zhang Y, Li ZH, Wang D, Shi CC, Shen TB, Shen F, Hu Y, Shen F. Endoscopic score predicting recurrence after foam sclerotherapy in grade I internal hemorrhoids: Development and external validation. World J Gastroenterol 2026; 32(39): 121904
- URL: https://www.wjgnet.com/1007-9327/full/v32/i39/121904.htm
- DOI: https://dx.doi.org/10.3748/wjg.121904